TABLE 2

Adjuvant Treatment

Treatmentn
Endocrine*48
 None9 (19%)
 Tamoxifen18 (37%)
 Tamoxifen plus aromatase inhibitor7 (15%)
 Aromatase inhibitor14 (29%)
Chemotherapy46
 None7 (15%)
 Adriamycin, cyclophosphamide, and taxol27 (59%)
 Cyclophosphamide, methotrexate, and fluorouracil10 (22%)
 Other2 (4%)
Radiation25 (54%)

  • ↵* Includes 2 patients who did not undergo surgery.